741 - 750 of 6433 Results
Title
Year
-
OPENTitle: M1 Muscarinic Receptors Modulate Fear-Related Inputs to the Prefrontal Cortex: Implications for Novel Treatments of Posttraumatic Stress DisorderJournal Name: Biological PsychiatryPublisher: Elsevier BVVol: 85Issue #: 12Start Page: 989End Page: 1000Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.biopsych.2019.02.020Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6555658Citation Count: 33
-
OPENTitle: A Systems-Based Map of Human Brain Cell-Type Enriched Genes and Malignancy-Associated Endothelial ChangesJournal Name: Cell ReportsPublisher: Elsevier BVVol: 29Issue #: 6Start Page: 1690End Page: 1706.e4Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.celrep.2019.09.088Best OA location URL: http://www.cell.com/article/S2211124719312926/pdfCitation Count: 30
-
OPENTitle: The experience of off periods: Qualitative analysis of interviews with persons with Parkinson's and carepartnersJournal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 1Issue #:Start Page: 31End Page: 36Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.prdoa.2019.07.008Best OA location URL: https://doi.org/10.1016/j.prdoa.2019.07.008Citation Count: 10
- Nutritional ketosis for mild cognitive impairment in Parkinson's disease: A controlled pilot trial2019OPENTitle: Nutritional ketosis for mild cognitive impairment in Parkinson's disease: A controlled pilot trialJournal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 1Issue #:Start Page: 41End Page: 47Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.prdoa.2019.07.006Best OA location URL: https://doi.org/10.1016/j.prdoa.2019.07.006Citation Count: 55
- Prediction of cognitive progression in Parkinson's disease using three cognitive screening measures2019OPENTitle: Prediction of cognitive progression in Parkinson's disease using three cognitive screening measuresJournal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 1Issue #:Start Page: 91End Page: 97Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.prdoa.2019.08.006Best OA location URL: https://doi.org/10.1016/j.prdoa.2019.08.006Citation Count: 30
-
OPENTitle: Transportation innovation to aid Parkinson disease trial recruitmentJournal Name: Contemporary Clinical Trials CommunicationsPublisher: Elsevier BVVol: 16Issue #:Start Page: 100449End Page: 100449Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.conctc.2019.100449Best OA location URL: https://doi.org/10.1016/j.conctc.2019.100449Citation Count: 9
-
OPENTitle: Dopamine effects on frontal cortical blood flow and motor inhibition in Parkinson's diseaseJournal Name: CortexPublisher: Elsevier BVVol: 115Issue #:Start Page: 99End Page: 111Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.cortex.2019.01.016Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6513702Citation Count: 30
-
OPENTitle: Increased yield of full GBA sequencing in Ashkenazi Jews with Parkinson's diseaseJournal Name: European Journal of Medical GeneticsPublisher: Elsevier BVVol: 62Issue #: 1Start Page: 65End Page: 69Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.ejmg.2018.05.005Citation Count: 61
-
OPENTitle: The second generation mixed lineage kinase-3 (MLK3) inhibitor CLFB-1134 protects against neurotoxin-induced nigral dopaminergic neuron lossJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 318Issue #:Start Page: 157End Page: 164Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.expneurol.2019.05.002Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6592621Citation Count: 11
- Cysteine oxidation and redox signaling in dopaminergic neurons physiology and in Parkinson’s disease2019OPENTitle: Cysteine oxidation and redox signaling in dopaminergic neurons physiology and in Parkinson’s diseaseJournal Name: Current Opinion in PhysiologyPublisher: Elsevier BVVol: 9Issue #:Start Page: 73End Page: 78Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.cophys.2019.04.025Best OA location URL: https://ars.els-cdn.com/content/image/1-s2.0-S2468867319300859-fx1_lrg.jpgCitation Count: 9